Ashish Thavkar

Sir, I had a question on this entire BIOSECURE Act. So, as and when it becomes a law in the US, where do you see the first part of benefit coming in? Would it be at the early stage of clinics like a discovery stage or you feel it could immediately also flow to the customs on this side of the business?

By any chance, would you guys also be there on the GLP-1 side of the thing?

Just last question from my side, so you said second-half will be a recovery, but given the fact that first half saw a revenue decline, are you saying for the full year of FY25, we will see a growth?